Pamela Garzone
Pfizer Inc., USA
Biography
Pamela Garzone has 5 years teaching and research experience at the University of Pittsburgh. She has worked in the biotech-pharma industry in Preclinical and Clinical positions, having increasing responsibilities over this time. She has extensive drug development experience in therapeutic areas such as oncology, hematology, immunology, neuroscience, and cardiovascular and infectious diseases. She joined Pfizer in 2009 as an Executive Director and became the Clinical Team Lead for the Early Development Programs at Rinat, a research unit of Pfizer. In 2015, she was promoted to VP, Group Asset Team Lead, responsible for the development strategy of assets within the Oncology Research Unit. In addition, she is currently the Interim Head of the Early Oncology Development and Clinical Research Group.
Abstract
Abstract : An engineered pH sensitive PCSK9 antibody to enhance pharmacokinetic and pharmacodynamic properties
